Utilization of plasma Aβ and p ‐tau217 in predicting Aβ accumulation in PET A‐ non‐demented participants

Abstract

Background: As Alzheimer's disease studies increasingly utilize plasma biomarkers, the associations of plasma and PET biomarkers of β‐amyloid (Aβ) in relation to Aβ accumulation and progression from PET A‐ to A+ must be better understood.